SKI Market

A+| A| A-|

Indian Indices

Sensex

77,286.77 399.86
( 0.52%)

Global Indices

Nasdaq

49,166.29 -22.51
(-0.05%)

Dow Jones

7,159.57 -35.34
(-0.49%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,332.91 11.82
(0.11%)

Forex

USD-INR

94.18 0.27
(0.28%)

EUR-INR

110.46 0.44
(0.40%)

GBP-INR

127.53 0.53
(0.42%)

JPY-INR

0.59 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

24.37

113075.15

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.59

Back

Varvee Global standalone net profit rises 23.46% in the September 2025 quarter

Nov 13,2025

Net profit of Varvee Global rose 23.46% to Rs 10.21 crore in the quarter ended September 2025 as against Rs 8.27 crore during the previous quarter ended September 2024. Sales rose 79.78% to Rs 27.83 crore in the quarter ended September 2025 as against Rs 15.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	27.83	15.48	80
OPM %	49.73	-30.17	-
PBDT	20.33	25.77	-21
PBT	18.80	24.65	-24
NP	10.21	8.27	23

77,286.77 399.86 ( 0.52%)

49,166.29 -22.51 (-0.05%)

7,159.57 -35.34 (-0.49%)

59,839.06 -698.30 (-1.15%)

10,332.91 11.82 (0.11%)

94.18 0.27 (0.28%)

110.46 0.44 (0.40%)

127.53 0.53 (0.42%)

0.59 0.00 (0.34%)